News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Drug Stunts Tumor Growth, Cylene Pharmaceuticals, Inc. Reveals



7/18/2012 7:46:19 AM

Cancer is a leading cause of death globally. Now, researchers are breaking ground on new ways to cut off the ability for cancer cells to grow. RNA Polymerase I (Pol I) activity is essential for cancer cell survival. Scientists are discovering that its inhibition selectively activates p53 (tumor suppressor protein) to kill tumors. Cylene Pharmaceuticals, founded by Daniel Von Hoff the worlds leading clinical oncologist, has found that the Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant cells but not in normal cells.

Read at Ivanhoe


comments powered by Disqus
Ivanhoe
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES